Argentina has approved Russia's one-dose Sputnik Light as a standalone COVID-19 vaccine and a booster shot, Reuters news agency reported on Monday.
The Russian Direct Investment Fund (RDIF), Russia's sovereign wealth fund, citing Argentina's health ministry, said a study in Argentina showed Sputnik Light was an "effective universal booster" when combined with vaccines produced by AstraZeneca (LON:AZN), Moderna (Nadaq:MRNA), China's Sinopharm and CanSino Biologics Inc.
RDIF markets Sputnik V internationally.
Reportedly, Argentina was one of the first countries to widely use Russia's Sputnik V COVID-19 vaccine.
Pfizer reports positive Phase 3 data for ABRYSVO in adults at risk for RSV disease
Clover Bio announces SCB-1019 vaccine candidate Phase I trial data in initial young adult cohort
Sanofi launches Verorab for rabies prophylaxis in UK
BioVaxys expands patent portfolio for DPX delivery platform and advances DPX SurMAGE
YS Biopharma repays USD40m loan facility
Kintara Therapeutics and TuHURA Biosciences to merge
VGXI names new chief accounting officer
Moderna reports positive interim results from next-generation COVID-19 vaccine trial
Valneva launches Phase 1 trial for next-generation Zika vaccine
Circio Holding ASA confirms licensing deal with IOVaxis Therapeutics in China and Singapore
Everest Medicines names new chief medical officer and chief product officer
Pfizer's PREVENAR 20 gains European Commission approval for paediatric pneumococcal vaccine